ijms-logo

Journal Browser

Journal Browser

Application of Pulsed Electric Fields in Cancer Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 20 September 2026 | Viewed by 245

Special Issue Editor


E-Mail Website
Guest Editor
Center of BioElectrics, Old Dominion University, Norfolk, VA, USA
Interests: cancer nanosecond electric pulses; gene electrotransfer and enhanced technology and its applications; nanosecond electric pulse (nsEPs); tumor ablation

Special Issue Information

Dear Colleagues,

Pulsed electric field (PEF) technologies represent an emerging nonthermal and minimally invasive physical modality for cancer treatment, extensively investigated in both preclinical models and clinical trials. Various PEF generation and delivery systems have been developed to target tumors through different mechanisms. PEFs with micro- to millisecond pulse durations at lower field strengths can induce reversible electroporation, facilitating drug and gene delivery, while microsecond PEFs at higher intensities can cause irreversible electroporation (IRE) to ablate tumors directly.

In contrast, nanosecond PEFs (nsPEFs) can penetrate intracellular organelles, modulating cellular bioelectricity and functions—ranging from stimulation and suppression to damage or death, depending on pulse parameters. When applied in vivo, PEFs can also influence the tumor microenvironment, including vascular and immune cell responses, further affecting tumor progression. Moreover, PEF-based approaches can be readily combined with standard cancer therapies to enhance treatment efficacy.

This Special Issue welcomes original research articles, short communications, and comprehensive reviews that advance understanding of PEF technologies in cancer therapy, including mechanistic insights, technological innovations, combinational strategies, and translational or clinical studies.

Dr. Siqi Guo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pulsed electric fields
  • cancer therapy
  • ablation
  • minimally invasive
  • tumor microenvironment
  • combination therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 7035 KB  
Article
Minimization of Cancellation Effect with Nisin During Bipolar Nanosecond Electrochemotherapy
by Veronika Malyško, Aušra Nemeikaitė-Čėnienė, Olga Michel, Arnoldas Morozas, Zofia Łapińska, Eglė Mickevičiūtė-Zinkuvienė, Paulina Malakauskaitė, Augustinas Želvys, Barbora Lekešytė, Justinas Ivaška, Julita Kulbacka and Vitalij Novickij
Int. J. Mol. Sci. 2026, 27(10), 4523; https://doi.org/10.3390/ijms27104523 - 18 May 2026
Abstract
Bipolar cancellation (BPC) is an efficiency-limiting phenomenon in bipolar nanosecond pulsed electric field (nsPEF) exposures, in which the second, opposite-polarity phase reduces or partially reverses the electroporation induced by the first phase. Nisin, a cationic antibiotic peptide, has been reported to interact with [...] Read more.
Bipolar cancellation (BPC) is an efficiency-limiting phenomenon in bipolar nanosecond pulsed electric field (nsPEF) exposures, in which the second, opposite-polarity phase reduces or partially reverses the electroporation induced by the first phase. Nisin, a cationic antibiotic peptide, has been reported to interact with lipid membranes in bacterial systems and artificial bilayer models, where it may contribute to membrane destabilization and increased permeability during pulsed electric field exposure. This study investigated whether nisin may enhance the efficacy of bleomycin electrochemotherapy (ECT) in the presence of bipolar nanosecond pulses, which are typically associated with pronounced BPC effects. Pulsed electric field (PEF) parameters and drug concentrations were selected based on preliminary viability and Yo-Pro-1 uptake experiments in CLS-354 human squamous cell carcinoma cells. To evaluate the effect of nisin, cell viability and membrane permeabilization were assessed following exposure to 300 ns pulses across a range of bipolar PEF protocols, with or without nisin, while identical unipolar pulses were used for comparison. Nisin (50 µg/mL) increased membrane permeabilization across the tested range of field amplitudes (9–15 kV/cm) and burst repetition frequencies (0.1–1.66 MHz). The presence of nisin was also associated with increased efficacy of bleomycin-based ECT under both unipolar and symmetrical bipolar PEF conditions. Under the optimized parameters tested (13 kV/cm; 150 pulses of 300 ns at 1.66 MHz), bipolar nsPEFs in combination with nisin reached levels of efficacy comparable to those observed with unipolar waveforms, suggesting a potential attenuation of bipolar cancellation effects. Full article
(This article belongs to the Special Issue Application of Pulsed Electric Fields in Cancer Therapy)
Show Figures

Figure 1

Back to TopTop